Table of contents

• Diet Pills at a Glance
• What Are Diet Pills?
• Who Is a Good Candidate for Diet Pills?
• What Are the Different Types of Diet Pills?
• Why Visit Korea for Diet Pills?
• Key Information for International Patients
• Which Are the Best Clinics in Korea for Diet Pills?
• Diet Pills From Start to Finish
• Alternatives to Diet Pills
• How Can I Prepare for Diet Pills?
• Aftercare Advice

Considering treatment in Korea? Everything you need to know e.g. — how to avoid scams, visas, interpreters, recovery tips — in our Medical Tourism Master Guide. Plan with confidence in minutes, not weeks!

Last updated: September 2026

Diet Pills at a Glance

• What it is — Diet pills are regulated prescription anti-obesity medicines—not slimming teas or unverified supplements—used alongside nutrition, activity, sleep, and behavioral support; options include weekly or daily GLP-1/GIP injections and oral medicines.
• Who may qualify — Korean guidance may consider medication after lifestyle treatment from BMI 25 kg/m², or BMI 23 kg/m² with an obesity-related condition; this lower Asian-population threshold does not guarantee eligibility for cosmetic weight loss or short-term visitors.
• Results and duration — Appetite changes and side effects may start within days to weeks, but weight loss should be assessed over months; treatment commonly continues long term because weight regain is common after stopping.
• No recovery downtime — There is no surgery, wound care, or routine activity restriction, and normal daily activity can usually resume immediately, though nausea, vomiting, diarrhea, constipation, dizziness, or insomnia can occur during initiation or dose increases.
• Korea visit requirements — Allow 1–2 business days for an in-person examination, any indicated tests, prescription decision, and pharmacy collection; a Korean prescription requires direct clinical assessment, and foreign prescriptions should not be assumed refillable locally.
• Ongoing follow-up is essential — These medicines require repeat prescriptions, dose titration, weight and blood-pressure checks, and adverse-effect monitoring, so home-country follow-up should be arranged within 2–4 weeks of starting and around dose increases.
• Key travel limitation — Korea offers brands including Wegovy and Mounjaro, but real-time stock, pen strength, visitor prescribing, legal import, refrigeration, and home-country refills must be confirmed before purchase; avoid a first GLP-1/GIP injection immediately before a long-haul flight.

What Are Diet Pills?

Diet pills are prescription anti-obesity medicines that support medical weight management alongside nutrition, activity, sleep, and behavioral care. They address excess body fat and related health conditions by reducing appetite, affecting cravings, or reducing fat absorption to support sustained weight loss. This is a non-surgical treatment that requires clinician assessment, dose adjustment, and ongoing monitoring.

Who Is a Good Candidate for Diet Pills?

• Adults with clinically significant excess adiposity — Good candidates have obesity or excess weight associated with conditions such as type 2 diabetes, hypertension, dyslipidemia, sleep apnea, or fatty liver disease, and have had an inadequate response to structured lifestyle treatment.
• Patients meeting Korean assessment thresholds — Korean guidance can consider pharmacotherapy from BMI 25 kg/m², or BMI 23 kg/m² with an obesity-related comorbidity, using lower Asian-population risk thresholds than many Western labels. Korean clinical guidance supports assessment based on more than BMI alone.
• People prepared for continuing care — Suitable patients can arrange medication supply, dose titration, nutrition and activity support, and monitoring with a clinician after returning home.
• Patients seeking medical weight management rather than rapid cosmetic loss — Prescription treatment is intended for chronic weight management, not short-term reduction before an event.

Pregnancy, planned pregnancy, personal or family history of medullary thyroid carcinoma (MTC) or MEN2, and important drug-specific contraindications can rule out particular medicines. Semaglutide should be stopped at least two months before a planned pregnancy. Uncontrolled hypertension, seizure history, eating disorders, opioid treatment, recent MAOI use, glaucoma, hyperthyroidism, malabsorption, cholestasis, pancreatitis history, gallbladder symptoms, kidney impairment, and uncontrolled psychiatric illness all require individualized medication selection or may prevent treatment. Assessment must also address waist circumference, blood pressure, diabetes medicines, mental-health history, eating-disorder symptoms, and reproductive plans; a brief overseas visit is not an adequate substitute for this review.

What Are the Different Types of Diet Pills?

“Diet pills” should mean regulated prescription anti-obesity medication, not slimming teas, stimulant supplements, unlabelled herbal products, or injections of uncertain origin. Drug selection depends on medical history, interacting medicines, pregnancy risk, route preference, eating pattern, and capacity for long-term monitoring.

• GLP-1 receptor agonists: Saxenda and Wegovy — Liraglutide 3 mg (Saxenda) is a daily injection; semaglutide 2.4 mg (Wegovy) is a weekly injection. Both reduce appetite and increase fullness, with gradual dose escalation to improve tolerability. Nausea, vomiting, diarrhea, constipation, abdominal discomfort, dehydration, gallbladder disease, and pancreatitis symptoms need attention.
• Dual GIP/GLP-1 agonist: Mounjaro — Tirzepatide is a weekly injection that also requires stepwise titration. Delayed gastric emptying can affect oral medicines; discuss backup contraception when using oral hormonal contraception around initiation and dose increases.
• Naltrexone/bupropion ER: Contrave — This oral combination targets appetite, cravings, and reward-driven eating. It requires gradual escalation and monitoring of blood pressure, pulse, mood, alcohol intake, and interactions. It is not suitable with seizure risk, uncontrolled hypertension, chronic opioid treatment, bulimia or anorexia, another bupropion product, or MAOI use within 14 days.
• Phentermine/topiramate ER: Qsymia — This oral appetite-suppressing combination is generally taken in the morning. Insomnia, dry mouth, constipation, increased heart rate, mood changes, and cognitive effects can occur. Pregnancy prevention and testing are essential because topiramate can harm a fetus; do not stop the highest dose abruptly because tapering reduces seizure risk.
• Fat-absorption inhibitor: Xenical — Orlistat is taken with fat-containing meals and reduces dietary-fat absorption rather than appetite. High-fat meals increase oily stool, urgency, spotting, and flatulence with discharge. It can reduce absorption of fat-soluble vitamins and interact with levothyroxine, cyclosporine, warfarin, amiodarone, selected antiepileptics, and some antiretrovirals.
• Short-course sympathomimetic suppressants — Agents such as phentermine, diethylpropion, phendimetrazine, and mazindol require particular caution in hypertension, cardiovascular disease, anxiety, insomnia, substance-use risk, and stimulant or psychiatric-drug interactions. They are not appropriate as casual vacation prescriptions.

Why Visit Korea for Diet Pills?

Korea has branded prescription options for chronic obesity pharmacotherapy and applies Asian-population clinical risk thresholds in assessment. A Korean consultation can be useful when it includes a lawful in-person evaluation, clear English instructions, and a documented continuation plan at home. It is not evidence that starting treatment during a short trip is superior to care in the patient’s own country.

• Established branded options — Korean professional materials identify Xenical, Contrave, Qsymia, Saxenda, Wegovy, and Mounjaro among branded anti-obesity treatments available in the Korean market. Korean pharmacotherapy information records Wegovy’s October 2024 introduction and reports Mounjaro’s domestic launch in August 2025.
• Lower BMI thresholds reflect regional risk assessment — Korean obesity guidance considers pharmacotherapy at BMI 25 kg/m², or BMI 23 kg/m² with an obesity-related comorbidity, after lifestyle assessment. This is not automatic eligibility for visitors or for cosmetic weight loss.
• Prescription and examination requirements — Korean law generally requires prescription dispensing through a physician or dentist, and the treating clinician must directly examine the patient. Review the relevant Korean legal provisions before assuming a foreign prescription can be refilled locally.
• Important availability limit — Market availability does not establish real-time stock of a specific brand, dose, or pen strength, nor that a clinic will prescribe to a non-resident. Confirm these details directly shortly before travel.

Key Information for International Patients

• Minimum stay — Allow 1–2 business days for an in-person assessment, any indicated testing, prescription decision, and pharmacy collection. No inpatient stay, driver, companion, wound-healing period, or hotel recovery time is ordinarily required.
• Repeat care — Anti-obesity medicines are chronic treatments, not one-time procedures or treatment sessions. Weekly or daily injections, prescription renewals, dose escalation, weight checks, blood-pressure review, and adverse-effect monitoring continue after departure.
• Flight timing — There is no universal no-fly restriction after a consultation or self-injection. Avoid taking a first GLP-1/GIP injection immediately before a long-haul flight where possible; early nausea, vomiting, diarrhea, dizziness, and dehydration are harder to manage in transit.
• Itinerary impact — Normal activity can usually continue immediately, but schedule the first treatment day without demanding tours, alcohol-heavy plans, remote travel, or long transfers. Symptoms are more common after starting treatment or increasing the dose.
• Home-country follow-up — Arrange a clinician at home before travel, ideally with follow-up within 2–4 weeks of initiation and around planned dose increases. This is particularly important for people taking insulin, sulfonylureas, antihypertensives, psychiatric medicines, or contraception.
• Medicine transport — Keep medicines in hand luggage in original labelled containers. Carry prescription copies, a clinician letter, injection documentation, and needles where relevant. Travel medicine guidance stresses that destination and transit-country restrictions can differ.

Travel note: A prescription issued in Korea does not establish that the medicine can legally enter, be refrigerated during travel, or be refilled in the destination country. Confirm airline, transit, Korean-entry, and home-country rules before purchasing medication.

Which Are the Best Clinics in Korea for Diet Pills?

Listed below are some of the best clinics in Korea for diet pills.

1. 365mc Hospital

For diet-pill-related weight-management support, 365mc Hospital offers personalized dietary and nutrition consultations alongside its obesity-treatment and body-contouring services. You can discuss practical diet prescriptions tailored to your lifestyle, eating habits, and nutritional needs, with meal-diary app monitoring intended to support ongoing habit changes rather than a one-size-fits-all plan.

• URL: 365mc Hospital Website
• Location: Gangnam-gu, Seoul
• Diet and nutrition support:
  • Personalized dietary and nutritional consultations for weight management and maintenance.
  • Diet prescriptions tailored to your lifestyle, dietary habits, and nutritional needs.
  • Meal-diary app support for recording, storing, and analyzing dietary information.
  • Focus on practical, real-world dietary solutions.
• Related obesity-treatment services:
  • Specialized services focused on obesity treatment, fat reduction, and body contouring.
  • LAMS combines fat extraction with fat-dissolving injections for targeted reduction with minimal downtime, according to the clinic.
  • Surgical liposuction is offered for areas including the abdomen, back, chest, hips, neck, thighs, and arms.
• Recovery and follow-up:
  • A dedicated Recovery Center provides one-to-one intensive care on the day of surgery.
  • A structured post-operative program includes dietary consultations and may include hyperbaric oxygen chamber therapy.
  • The clinic also provides healthy-eating seminars and educational outreach on topics including child obesity and postpartum weight management.

2. Three Wishes Clinic - Myeongdong

Three Wishes Clinic - Myeongdong does not list diet pills or a medical weight-management program in the provided information. If your goal is localized contouring rather than medication-based weight loss, you can ask about its fat-dissolving injections, which are described for small deposits around the chin, jowls, and jawline.

• URL: Three Wishes Clinic - Myeongdong Website
• Location: Jung-gu, Seoul
• Relevant contouring option: Fat-dissolving injections are offered to address localized fat deposits in the chin, jowls, or jawline without surgery.
• Other listed services:
  • Petite procedures include Botox, dermal fillers, and thread lifting.
  • Skin services include Shurink ultrasound lifting, CO2 laser, laser hair removal, PDT acne treatment, chemical peels, Rejuran Healer, and customized skin care.
  • Semi-permanent makeup options include eyebrow, hairline and scalp, and lip microblading.

3. 365mc Hospital - Sinsa

365mc Hospital - Sinsa does not list diet pills in the provided information; its relevant focus is procedural fat reduction and body contouring. If you are considering an alternative to medication-based weight management for specific areas, you can ask about its liposuction options and minimally invasive LAMS procedure.

• URL: 365mc Hospital - Sinsa Website
• Location: Seoul
• Body-contouring procedures:
  • Abdominal liposuction for excess midsection fat.
  • Arm, thigh, love-handle, and face liposuction options for targeted contouring.
  • Face liposuction addresses areas such as the chin and neck to refine facial contours.
• Minimally invasive option: LAMS is described as combining liposuction with precise body contouring for targeted treatment and minimal downtime.

Diet Pills From Start to Finish

1. Send records before travel — Request an English or virtual pre-consultation where offered. Provide height, weight trend, waist measurement if available, prior weight-management attempts, diagnoses, allergies, surgeries, current medicines and supplements, alcohol or recreational-drug use, menstrual history, pregnancy plans, and home clinician contact details.
2. Confirm practical prescribing arrangements — Ask which generic and brand options, strengths, and quantities are available; whether the clinician assesses non-residents; whether dispensing is through the clinic or a pharmacy; and whether English injection teaching and written instructions are supplied. Do not assume a foreign prescription is refillable in Korea.
3. Attend the in-person assessment — The clinician records weight, height, BMI, waist circumference, blood pressure, and pulse, then reviews eating pattern, activity, sleep and possible sleep apnea, weight-related disease, mental health, medication interactions, and pregnancy risk.
4. Complete indicated tests — Glucose or HbA1c, lipid profile, liver and kidney function, thyroid testing, and blood count are used when clinically indicated. ECG, abdominal imaging, sleep testing, endocrine investigations, or cardiovascular review are not routine for every patient.
5. Choose and start the medication plan — The prescriber matches the drug to contraindications, comorbidities, route preference, side-effect profile, and follow-up capacity. GLP-1/GIP medicines, Contrave, and Qsymia use gradual titration; the starting dose is not the maintenance dose.
6. Receive medicine-specific teaching — For injectable treatment, learn pen handling, injection technique, rotation of injection sites, storage, missed-dose steps, food and hydration measures, and symptoms that need urgent review. For oral medicines, receive timing, escalation, tapering, interaction, and contraception instructions where relevant.
7. Collect the prescription and leave with records — Same-day discharge is standard. Obtain an English medication list with generic name, brand, strength, start date, directions, titration schedule, test results, prescriber contact details, and urgent-care advice.
8. Continue remotely and at home — Contact the Korean clinic as arranged, but establish longitudinal care with a home clinician for dose changes, vital signs, nutrition, tolerability, diabetes-medication adjustment, pregnancy-risk review, and legal local supply.

Alternatives to Diet Pills

The right alternative depends on treatment severity and the goal. Non-surgical approaches avoid operative recovery but require sustained adherence and often produce more gradual change; surgery can deliver greater weight loss for selected patients but requires extensive pre-operative evaluation and lifelong follow-up.

Structured Lifestyle Treatment

• Role — Nutrition therapy, physical activity, sleep management, behavioral support, and treatment of contributing medicines or medical conditions are foundational whether or not medication is used.
• Tradeoff — It avoids drug adverse effects but can be insufficient alone for patients with obesity-related disease or repeated weight regain.

Different Prescription Medication

• Role — Switching among approved anti-obesity drug classes can be appropriate after inadequate response, intolerance, contraindications, pregnancy planning, or a change in medicine availability.
• Tradeoff — Do not combine a GLP-1 medicine with another GLP-1, stimulant, appetite suppressant, herbal weight-loss product, or compounded product unless the prescriber specifically directs it.

Metabolic or Bariatric Surgery

• Role — Surgery can be considered for severe obesity or inadequately controlled obesity-related disease after comprehensive multidisciplinary evaluation.
• Tradeoff — It is not interchangeable with a brief medication visit: it involves anesthesia, operative risks, nutritional monitoring, and substantial long-term follow-up.

Diet Korean Medicine

• Role — Diet Korean medicine is marketed as a non-surgical weight-management option.
• Tradeoff — Do not assume it is safer than regulated pharmacotherapy or equivalent for durable weight management. Request full ingredient disclosure, review possible interactions, and discuss regulatory status with a qualified clinician.

How Can I Prepare for Diet Pills?

• Send a full medication list — Disclose insulin, sulfonylureas, opioids including methadone or buprenorphine, antidepressants, antipsychotics, MAOIs, benzodiazepines, antiepileptics, warfarin, levothyroxine, cyclosporine, amiodarone, antiretrovirals, hormonal contraception, and all supplements.
• Do not independently stop essential medicines — Continue diabetes, blood-pressure, thyroid, mental-health, seizure, anticoagulant, and pain medicines unless the treating doctor gives individualized instructions.
• Stop unregulated weight-loss products before assessment — Avoid slimming teas, “fat burners,” stimulant supplements, laxatives, diuretics, crash diets, prolonged fasting, dehydration regimens, imported injections, and undisclosed herbal products.
• Discuss pregnancy early — Tell the clinician about pregnancy, breastfeeding, plans to conceive, and contraceptive use. Semaglutide requires discontinuation at least two months before planned pregnancy; phentermine/topiramate requires pregnancy-risk counselling and testing before and during treatment.
• Prepare travel documentation — Bring original labelled containers, prescription copies, a clinician letter, and a current medication list. Put medicines in hand luggage and carry documentation for injectable pens and needles.
• Plan a low-demand first day — Eat and drink normally unless a clinic gives different instructions. No routine fasting, sun avoidance, compression garment, driver, or companion is needed, but avoid beginning treatment immediately before a long-haul flight or strenuous itinerary.
• Flag upcoming anesthesia or sedation — Tell the clinic and any anesthetic team about GLP-1/GIP treatment before surgery, endoscopy, or sedation. Peri-procedural management should be individualized rather than based on a universal stop rule, consistent with multi-society GLP-1 guidance.

Travel note: Book flexible travel where possible. Delayed pharmacy supply, a need for further tests, or early gastrointestinal symptoms can make a fixed departure plan impractical.

Confirm the treating clinic’s medication-specific preparation and dispensing requirements; those instructions take precedence over general guidance.

Aftercare Advice

Anti-obesity medication needs active monitoring, not surgical recovery: manage tolerability early and keep the home-country follow-up plan in place.

• Follow the titration schedule exactly — Do not accelerate dose increases to pursue faster weight loss. Gastrointestinal symptoms often appear after initiation or escalation; the prescriber can decide whether to hold, reduce, or change a dose.
• Protect hydration and nutrition — Use small, regular meals and drink fluids consistently, especially with nausea, vomiting, or diarrhea. Avoid crash dieting and heavy alcohol use, which can worsen dehydration and gastrointestinal symptoms.
• Continue sensible activity — Resume normal daily activity immediately and build sustainable exercise around fitness and medical conditions. Avoid driving, operating machinery, or hazardous tasks when dizziness, impaired concentration, severe nausea, or insomnia occurs.
• Know urgent warning signs — Seek urgent evaluation for severe or persistent abdominal pain, especially pain radiating to the back with or without vomiting; persistent vomiting or diarrhea with inability to keep fluids down; suspected gallbladder symptoms; severe allergic reaction; fainting; confusion; visual changes; severe depression or suicidal thoughts; or hypoglycemia symptoms when using insulin or a sulfonylurea.
• Arrange ongoing review — Monitor weight, blood pressure, adverse effects, nutrition, adherence, pregnancy risk, and diabetes medicines with the home clinician, commonly within 2–4 weeks after starting and around each planned dose increase. Reassess an inadequate response, often less than about 5% weight loss after three months at an appropriate therapeutic exposure.
• Set realistic expectations — Appetite changes and adverse effects can begin within days or weeks, but weight response should be judged over months. These medicines are chronic therapies, and weight regain is common after discontinuation; create a clinician-supervised maintenance plan before stopping.

Follow the treating doctor’s individualized instructions and contact the clinic promptly when symptoms seem unusual, severe, or worsening.